Delivery Order SPE2DB25D7067-SPE2DB25FSUXH

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.95 firm fixed-price contract is for Advair HFA 115-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.03 firm fixed-price delivery order is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a medical product used in respiratory care. The contract has an ultimate completion date of March 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,346.71 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhalers, with an ultimate completion date of April 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,240.83 and covers the supply of Advair HFA 45-21 MCG inhalers. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler. The $3,020.60 firm-fixed-price contract has an ultimate completion date of August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,116.49, is for the supply of Advair HFA 115-21 MCG inhalers to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024 and is a firm fixed price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,315.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. This award is not associated with any set-aside designation, indicating open competition. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,807.51 firm fixed-price contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a common pharmaceutical used to treat respiratory conditions. The order has a completion date of February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $14,173.59 and provides for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,806.05 Firm Fixed Price Delivery Order contract is for the supply of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a period of performance through May 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSUXH
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,661.61, is for the delivery of Advair HFA 45-21 MCG inhalers. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 11:07 AM